ロード中...
Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
Recent FDA approval of an allopregnanolone-based treatment specifically for postpartum depression, brexanolone, now commercially called Zulresso®, is an exciting development for patients and families impacted by postpartum depression and allows us to start asking questions about why and how this com...
保存先:
| 出版年: | Neurobiol Stress |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6838978/ https://ncbi.nlm.nih.gov/pubmed/31709278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100198 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|